PharmaShots | Incisive News in 3 Shots

Subscribe Now

Protein-Based Coronavirus Vaccines

Sorrento to License Dyadic's DYAI-100 and C1 Technology for Protein-Based Coronavirus Vaccines and Therapeutics

Sorrento to License Dyadic's DYAI-100 and C1 Technology for Protein-Based Coronavirus Vaccines and Therapeutics

August 12, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us